Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.

van de Velde, C.J.., Rea, D., Seynaeve, C., Putter, H., Hasenburg, A., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Hille, E., others, 2011.

Lancet 377, 321–331. doi:10.1016/S0140-6736(10)62312-4

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: The Lancet
TEAM
2011
REASON: TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients – Results from a German registry.

Thomas, M., Eberhardt, W., Graf von der Schluenburg, J., Dietel, M., Schirmacher, P., Gutendirf, B., Schaller, F., Schütte, W., 2011.

Onkologie 34 (suppl 6)(V451), 124.

Abstract

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Onkologie
REASON
2011
EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany – Initial Results from a German Registry.

Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, B., Zirrgiebel, U., Schütte, W., 2011.

EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Abstract 9015), 596.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: EMCC (ESMO) / Journal: -
REASON
2011
The treatment of lung cancer in German outpatient centres. Data from a clinical registry – TLK Registry.

Tessen, H.W., Hutzschenreuter, U., Steffens, C.C., Nusch, A., Spirik, J., Marschner, N., 2011.

Onkologie 34 (suppl 6)(P533), 153. doi:10.1159/000333301

Abstract

Download

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TLK
2011
Intention of Treating Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim and Change of Practice.

Tesch, H., Turner, M., Indorf, M., 2011.

SIOG Annual Meeting, Paris.

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: SIOG / Journal: -
HEXAFIL
2011
Diabetes and breast cancer. Data from a clinical registry – TMK Registry.

Tesch, H., Rauh, J., Fietz, T., Overkamp, F., Hartmann, H., Marschner, N., 2011.

Onkologie 34 (suppl 6)(V753), 221. doi:10.1159/000333303

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
TMK
2011
Analysis of the non-interventional study with Filgrastim-Hexal®: safety profile and patient perception.

Tesch, H., Indorf, M., Schmid, T., Rauh, J., Stoetzer, O., Schaller-Kranz, T., 2011

Onkologie 34 (suppl 6)(P867), 259. doi:10.1159/000333304

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
HEXAFIL
2011
Supportive Treatment of Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim: the HEXAFIL Non-Interventional Study.

Tesch, H., Indorf, M., Schaller-Kranz, T., 2011.

EMCC / ESMO (Poster 280, Abstract 4025), 308.

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: EMCC (ESMO) / Journal: -
HEXAFIL
2011
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.

Stemmler, H.J., Digioia, D., Freier, W., Tessen, H.W., Gitsch, G., Jonat, W., Brugger, W., Kettner, E., Abenhardt, W., Tesch, H., Hurtz, H.J., Rösel, S., Brudler, O., Heinemann, V., 2011.

Br J Cancer 104, 1071–1078. doi:10.1038/bjc.2011.86

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: British Journal of Cancer
Gemcitabine 02 MC
2011
Effectiveness and tolerability of ferric carboymaltose in the correction of cancer- and chemotherapy-associated anaemia – a multicenter observational study.

Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Rzychon, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011.

chemotherapy-associated anaemia – a multicenter observational study. EMCC / ESMO (Poster 294, Abstract 3000).

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: EMCC (ESMO) / Journal: -
Ferinject-NIS
2011